Copyright
©The Author(s) 2022.
World J Clin Oncol. Jul 24, 2022; 13(7): 630-640
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.630
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.630
Table 1 Characteristics of study patients according to carbohydrate antigen 19-9 value
Group A (n = 29) | Group B (n = 82) | P value | |
Patient demographics | |||
Age in yr, median | 64 | 67 | 0.241 |
Male sex | 58.62 | 70.73 | 0.333 |
At risk behaviors | |||
Smoking | 31.03 | 28.04 | 0.946 |
Drinker | 20.68 | 23.17 | 0.987 |
Clinical findings | |||
Abdominal pain | 55.17 | 76.83 | 0.048 |
Jaundice | 27.58 | 29.26 | 0.946 |
Weight loss | 62.06 | 63.41 | 0.924 |
Diabetes mellitus | 34.48 | 34.14 | 0.845 |
Tumor localization | |||
Head, neck and uncinate | 62.06 | 57.31 | 0.820 |
Body and tail | 37.93 | 42.68 | |
Tumor size in cm | |||
< 2 | 10.34 | 2.43 | 0.447 |
2-4 | 58.62 | 64.63 | |
> 4 | 31.03 | 32.92 | |
Staging | |||
Resectable | 13.79 | 7.31 | 0.714 |
Borderline resectable | 6.89 | 4.87 | |
Locally advanced | 20.68 | 24.39 | |
Metastatic | 58.62 | 63.31 | |
Outcome | |||
6-mo survival | 58.62 | 47.56 | 0.308 |
- Citation: Balaban DV, Marin FS, Manucu G, Zoican A, Ciochina M, Mina V, Patoni C, Vladut C, Bucurica S, Costache RS, Ionita-Radu F, Jinga M. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. World J Clin Oncol 2022; 13(7): 630-640
- URL: https://www.wjgnet.com/2218-4333/full/v13/i7/630.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i7.630